AdvoCare Compensation Plan Review

The AdvoCare compensation plan pays you for your value in the marketplace.

The more AdvoCare supplements that you and your team move into the market, the more you get paid.

spe
  • Earn up to 40% on product sales to your customers.
    .
  • Earn up to 20% on every product your Distributors sell
    .
  • Earn override commissions on your team volume
    .
  • Earn Leadership Bonuses of 3-19% on your complete organization
    .
  • Qualify to earn twice-a-month pay period bonuses when AdvoCare awards $20,000 to the top achieveing Rookie Advisors (Split $1,000;$1,500; $2,000; $2,500; $3,000; $4,000 and $6,000)
    .
  • Qualify for twice a year luxury vacations
space

There’s NO enrollment bonus when you sign up a new distributor, which gets a lot of companies in trouble for rewarding recruiting instead of product sales.

When a new Distributor places an Advisor order for $3,000 in products, you earn 10% or $300.  So you get paid on product moving out of the warehouse, not just for recruiting.

Your new Distributor gets a 30% discount on the order, so they only paid $2,100.  When you help them get into action and move the products to people to get started on the 24 Day Challenge Program, they can earn up to $900 in retail sales.

That’s win-win!

The AdvoCare compensation plan gives you the opportunity to get paid what you’re worth, and they provide a free DebtBuster program to help you eliminate your debts, so that you can achieve financial freedom, and more importantly, time freedom.

AdvoCare 24 Day Weight Loss Challenge ProgramNow is the time to experience personal health, financial well-being and a well-lived life.

Join us and BEcome a Champion of your best life now!

Optimize your weight and health with the
Weight Loss AdvoCare 24 Day Challenge


.

P.S. If this page was valuable to you, please use the Twitter, Facebook or LinkedIn Share buttons to Pay It Forward.
Your Kindness Could Change Someones Life!
  • Facebook
  • Twitter
  • LinkedIn
  • email
  • Add to favorites

Comments on this entry are closed.